High Response Rate to Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Indolent Non-Hodgkin Lymphoma
Authors:
- Adrian J.C. BloorABAdrian J.C. Bloor
- Kirsty ThomsonKTKirsty Thomson
- Noha ChowdhryNCNoha Chowdhry
- Stephanie VerfuerthSVStephanie Verfuerth
- Stuart J. IngsSIStuart J. Ings
- Ronjon ChakravertyRCRonjon Chakraverty
- David C. LinchDLDavid C. Linch
- Anthony H. GoldstoneAGAnthony H. Goldstone
- Karl S. PeggsKPKarl S. Peggs
- Stephen MackinnonSMStephen Mackinnon
Open Access
- 1 January 2008
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 14 (1) , 50-58
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantationBone Marrow Transplantation, 2005
- The graft-versus-lymphoma effect: clinical review and future opportunitiesBone Marrow Transplantation, 2005
- The role of allogeneic transplantation in non-Hodgkin's lymphomaBritish Journal of Haematology, 2005
- Graft-versus-lymphoma effects: Clinical review, policy proposals, and immunobiologyTransplantation and Cellular Therapy, 2004
- Syngeneic Hematopoietic Stem-Cell Transplantation for Non-Hodgkin’s Lymphoma: A Comparison With Allogeneic and Autologous Transplantation—The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow TransplantationJournal of Clinical Oncology, 2003
- Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphomaBlood, 2003
- An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantationBone Marrow Transplantation, 2003
- Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin’s lymphoma (NHL): results of a provincial strategyBone Marrow Transplantation, 2000
- Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patientsBlood, 1990
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979